These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 15378666

  • 1. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
    Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG.
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
    [Abstract] [Full Text] [Related]

  • 2. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
    Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM.
    Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
    [Abstract] [Full Text] [Related]

  • 3. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT, Isaac MB, Gallo F, Tournoux A.
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 5. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM, Palmer RH, Gendreau RM, Chen W.
    Psychosomatics; 2012 Sep; 53(4):371-9. PubMed ID: 22677218
    [Abstract] [Full Text] [Related]

  • 6. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
    Matthey A, Cedraschi C, Piguet V, Besson M, Chabert J, Daali Y, Courvoisier D, Montagne A, Dayer P, Desmeules JA.
    Pain Physician; 2013 Sep; 16(5):E553-62. PubMed ID: 24077206
    [Abstract] [Full Text] [Related]

  • 7. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
    Geisser ME, Palmer RH, Gendreau RM, Wang Y, Clauw DJ.
    Pain Pract; 2011 Sep; 11(2):120-31. PubMed ID: 20642487
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
    Lopez-Ibor JJ, Conesa A, Spanish Milnacipran/Imipramine Study.
    Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y.
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [Abstract] [Full Text] [Related]

  • 11. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y.
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 13. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 14. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T, Färber L, Varga B, Baumgartner C, Haus U, Müller W.
    Drugs Exp Clin Res; 2001 Mar; 27(3):113-8. PubMed ID: 11447769
    [Abstract] [Full Text] [Related]

  • 15. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group.
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
    Jensen KB, Petzke F, Carville S, Choy E, Fransson P, Gracely RH, Vitton O, Marcus H, Williams SC, Ingvar M, Kosek E.
    J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.